Cargando…
Detecting protein variants by mass spectrometry: a comprehensive study in cancer cell-lines
BACKGROUND: Onco-proteogenomics aims to understand how changes in a cancer’s genome influences its proteome. One challenge in integrating these molecular data is the identification of aberrant protein products from mass-spectrometry (MS) datasets, as traditional proteomic analyses only identify prot...
Autores principales: | Alfaro, Javier A., Ignatchenko, Alexandr, Ignatchenko, Vladimir, Sinha, Ankit, Boutros, Paul C., Kislinger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514513/ https://www.ncbi.nlm.nih.gov/pubmed/28716134 http://dx.doi.org/10.1186/s13073-017-0454-9 |
Ejemplares similares
-
Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes
por: Govindarajan, Meinusha, et al.
Publicado: (2022) -
A proteomic investigation of isogenic radiation resistant prostate cancer cell lines
por: Kurganovs, Natalie, et al.
Publicado: (2021) -
Endoplasmic Reticulum Protein Targeting of Phospholamban: A Common Role for an N-Terminal Di-Arginine Motif in ER Retention?
por: Sharma, Parveen, et al.
Publicado: (2010) -
Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology
por: Cox, Brian, et al.
Publicado: (2009) -
A Combination of H2A.Z and H4 Acetylation Recruits Brd2 to Chromatin during Transcriptional Activation
por: Draker, Ryan, et al.
Publicado: (2012)